Article

Prime Global and Raremark Partner for Patients with Rare Diseases

Prime Global and Raremark have announced a partnership aiming to transform solutions for patients with rare diseases.

The partnership will combine Raremark’s Xperiome platform for patients with Prime Global’s 23 years of medical communications experience aiming to uncover insights into the entire patient journey that will allow the creation of a patient-centric drug development and commercialization programs.

For more information, click here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.